InvestorsHub Logo

namtae

01/28/17 10:01 AM

#240867 RE: jour_trader #240865

But I thought the approval rate for Priority Review NDAs was over 90%??

That doesnt sound like the FDA has been a big mystery to get drugs approved

Face facts, Elite has bumbled its opportunity, which never really existed in the first place.

With a 90% approval rate, nobody can point the finger at the FDA.

Point it at ELITE!!

This is why Elite shares trend lower and lower...and when reality finally sets in, the share price will collapse!!

dr_lowenstein

01/28/17 12:08 PM

#240876 RE: jour_trader #240865

Yes I agree with that, we have seen this for example in the case of biosimilars where politics was clearly a factor. However, there is no evidence that is the case with secretox approval.